CURBSIDE CONSULTS™ BY RISE Consult 08 | Growth & Go-to-Market

Knowing who is involved helps you navigate an opportunity. Understanding how they reach agreement helps you move it forward.

By Carl Wooten, Founder, RISE 5-minute read

The Signal

The meeting went well.

The commercial leader understood the value. Your champion asked for a proposal. Someone mentioned a budget. The team agreed to bring in IT, procurement, and compliance.

You updated the opportunity. The next step looked clear.

Then the questions changed. IT wanted to understand the integration burden. Compliance needed more clarity about how the solution would be used. Procurement asked whether an existing partner could do the work. Another leader questioned whether the organization had the capacity to implement it.

Your champion still liked the solution.

The decision stopped moving. For companies selling technology and services into pharma and biotech, this is a familiar moment. A promising opportunity enters the enterprise—and encounters the people who must make it workable.

A stakeholder list can tell you who is involved. It rarely tells you how their concerns, responsibilities, and dependencies combine to produce a decision.

That requires a deeper view.

Why It Matters

A buying committee is a collection of people.

A decision system includes the relationships between those people: who influences whom, which concerns carry weight, what evidence earns confidence, and how competing priorities get resolved.

Consider a hypothetical AI solution for a pharmaceutical commercial organization.

The commercial sponsor sees an opportunity to improve performance.

IT sees architecture, security, integration, and support requirements. Legal and compliance see questions about data, intended use, oversight, and accountability.

Finance sees an investment that must justify its cost.

Field leadership sees another change competing for attention.

Each perspective is reasonable. Each person is evaluating a different consequence of the same decision.

The seller’s challenge is to help those perspectives come together around a workable path.

That becomes difficult when the opportunity is managed mainly through titles and meeting attendance. An executive may control the budget while relying heavily on someone else’s judgment. A person outside the formal committee may shape the implementation team’s willingness to proceed. A supportive stakeholder may agree with the business case while remaining uncomfortable with the risk.

This is why “everyone likes it” can coexist with “no one is ready to approve it.”

Interest is individual. Commitment must survive the organization.

The Curbside View

A strong enterprise opportunity gives the organization a shared reason—and a credible way—to move forward.

At RISE, The Path to Yes™ begins with understanding what a decision requires from the people who must make it, defend it, and live with it.

Your champion is part of that path. So are the people who will absorb the work, answer the difficult questions, and remain accountable after the contract is signed. A champion who believes in your solution may still lack the authority, relationships, or capacity to create agreement across those groups.

More enthusiasm will only take them so far.

They need a business case that travels. They need evidence that addresses different concerns. They need an implementation approach that their colleagues can support. And they need to know which questions must be resolved before the next commitment becomes possible. The practical implication is simple: treat internal alignment as work that must be designed into the opportunity.

Ask your champion:

“What will your colleagues need to understand before they can support this?”

That question often reveals more than another request for a decision date.

The Move

Take one important opportunity this week and build a one-page view of how the decision will happen.

Start with five questions.

1. What decision are we actually asking the organization to make?

Be specific. Approval for an exploratory conversation, a limited pilot, and an enterprise deployment require different levels of confidence.

Define the immediate commitment. Then identify what must be true for that commitment to make sense.

2. Who owns the outcome—and who carries the consequences?

Identify the person accountable for the business result. Then look at who will handle implementation, change workflows, provide oversight, or support users.

People carrying the consequences need a voice early enough to shape the approach.

3. What does each stakeholder need to believe?

The sponsor may need confidence in the business value. IT may need confidence in the architecture and support model. Compliance may need confidence in the controls. Users may need confidence that the solution will make their work easier.

Write those requirements in plain language. “Needs to see the demo” is an activity. “Needs confidence that the workflow fits existing responsibilities” is a decision requirement.

4. Whose judgment changes other people’s confidence?

Look beyond formal authority. Who does the sponsor trust? Who can explain the operational realities? Who can bring unresolved concerns into the open? Who can help colleagues reach agreement?

Understanding those relationships helps you support the internal conversation.

5. What is the next unresolved condition?

Choose the condition that currently prevents progress.

It might be an unclear success measure, an unanswered data question, a missing implementation owner, or uncertainty about the resources required. Agree on how to resolve it, who will own the work, and what decision can follow.

You now have a more useful next step than “follow up next week.”

You have a reason for the organization to move.

One Question to Take With You

If your champion stepped away tomorrow, would the organization still understand why this matters—and how to move forward?

Your answer reveals how much of the opportunity rests on one person, and how much has become a shared organizational commitment.

Carl Wooten is the founder of RISE, helping pharma, biotech, and the companies serving them move forward when the path ahead is anything but certain.

RISE | AI Powered. Human Led.

Read the original LinkedIn publication

Continue the conversation

Get the next Curbside Consult